News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Certara Corporation Announces Completion of Acquisition of Simcyp Limited


3/14/2012 6:32:03 AM

ST. LOUIS--(BUSINESS WIRE)--Certara™, a Vector Capital portfolio company and a leading provider of drug discovery and development software and scientific consulting services, today announced the completion of its acquisition of UK-based Simcyp Limited. Simcyp is a leading research company providing a modeling and simulation platform for predicting the fate of drugs in virtual populations, including pediatric populations. The now completed acquisition means Simcyp’s highly-regarded technologies will be integrated into planned Certara translational science initiatives.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES